metaLead Therapeutics
About:
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Website: https://metalead.ch
Top Investors: Venture Kick, BioInnovation Institute
Description:
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Total Funding Amount:
$661000
Headquarters Location:
Zürich, Zurich, Switzerland
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-08-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai